Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1996 Feb;80(2):135–139. doi: 10.1136/bjo.80.2.135

Disappearance and formation rates of microaneurysms in early diabetic retinopathy.

T Hellstedt 1, I Immonen 1
PMCID: PMC505404  PMID: 8814743

Abstract

AIM: To analyse the formation and disappearance rates of individual microaneurysms in mild background retinopathy. METHODS: Three fluorescein angiograms were taken at 1 year intervals during a 2 year follow up from 24 type 1 diabetics with mild background retinopathy. Microaneurysms were identified and localised twice from each angiogram using a computerised system for retrieval of the coordinates for each microaneurysm. Microaneurysms identified similarly in both sessions were then processed further to obtain rates of microaneurysm formation and disappearance, and microaneurysm count changes. RESULTS: In the whole material the total number of microaneurysms increased from 298 to 436 from baseline to 2 years. During the 2 year follow up 395 new microaneurysms formed and 258 microaneurysms disappeared. Of the microaneurysms present at baseline 174 (58%) were still present at the 1 year and 142 (48%) at the 2 year follow up. In patients with good glucose control (HbA1c < or = 7.5 mmol) microaneurysm formation showed a trend of being decreased whereas microaneurysm disappearance did not correlate with glucose control. CONCLUSION: Background diabetic retinopathy is a dynamic process. A significant proportion of microaneurysms present disappear within 2 years. This is compensated for by formation of new microaneurysms, the resultant net changes in microaneurysm counts being small. Microaneurysm formation and disappearance rates are new variables of diabetic retinopathy and may prove to be more sensitive indicators of the progression patterns of background diabetic retinopathy than microaneurysm count changes.

Full text

PDF
135

Images in this article

137Image
on p.137

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashton N. Vascular basement membrane changes in diabetic retinopathy. Montgomery lecture, 1973. Br J Ophthalmol. 1974 Apr;58(4):344–366. doi: 10.1136/bjo.58.4.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Auwerx J., Bouillon R., Collen D., Geboers J. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis. 1988 Jan-Feb;8(1):68–72. doi: 10.1161/01.atv.8.1.68. [DOI] [PubMed] [Google Scholar]
  3. Frank R. N. On the pathogenesis of diabetic retinopathy. A 1990 update. Ophthalmology. 1991 May;98(5):586–593. doi: 10.1016/s0161-6420(91)32253-x. [DOI] [PubMed] [Google Scholar]
  4. Frank R. N. On the pathogenesis of diabetic retinopathy. Ophthalmology. 1984 Jun;91(6):626–634. doi: 10.1016/s0161-6420(84)34258-0. [DOI] [PubMed] [Google Scholar]
  5. Hellstedt T., Palsi V. P., Immonen I. A computerized system for localization of diabetic lesions from fundus images. Acta Ophthalmol (Copenh) 1994 Jun;72(3):352–356. doi: 10.1111/j.1755-3768.1994.tb02772.x. [DOI] [PubMed] [Google Scholar]
  6. Klein R., Meuer S. M., Moss S. E., Klein B. E. The relationship of retinal microaneurysm counts to the 4-year progression of diabetic retinopathy. Arch Ophthalmol. 1989 Dec;107(12):1780–1785. doi: 10.1001/archopht.1989.01070020862028. [DOI] [PubMed] [Google Scholar]
  7. Kohner E. M., Dollery C. T. The rate of formation and disapearance of microaneurysms i diabetic retinopathy. Eur J Clin Invest. 1970 Nov;1(3):167–171. doi: 10.1111/j.1365-2362.1970.tb00613.x. [DOI] [PubMed] [Google Scholar]
  8. Kohner E. M., Sleightholm M. Does microaneurysm count reflect severity of early diabetic retinopathy? Ophthalmology. 1986 May;93(5):586–589. doi: 10.1016/s0161-6420(86)33692-3. [DOI] [PubMed] [Google Scholar]
  9. Kruithof E. K. Plasminogen activator inhibitors--a review. Enzyme. 1988;40(2-3):113–121. doi: 10.1159/000469153. [DOI] [PubMed] [Google Scholar]
  10. Kruithof E. K., Tran-Thang C., Bachmann F. The fast-acting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinase. Thromb Haemost. 1986 Feb 28;55(1):65–69. [PubMed] [Google Scholar]
  11. Little H. L. Alterations in blood elements in the pathogenesis of diabetic retinopathy. Ophthalmology. 1981 Jul;88(7):647–654. doi: 10.1016/s0161-6420(81)34971-9. [DOI] [PubMed] [Google Scholar]
  12. Porta M., Hilgard P., Kohner E. M. Platelet shape change abnormalities in diabetic retinopathy. Diabetologia. 1980 Mar;18(3):217–221. doi: 10.1007/BF00251919. [DOI] [PubMed] [Google Scholar]
  13. Speiser P., Gittelsohn A. M., Patz A. Studies on diabetic retinopathy. 3. Influence of diabetes on intramural pericytes. Arch Ophthalmol. 1968 Sep;80(3):332–337. doi: 10.1001/archopht.1968.00980050334007. [DOI] [PubMed] [Google Scholar]
  14. Vague P., Juhan-Vague I., Aillaud M. F., Badier C., Viard R., Alessi M. C., Collen D. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism. 1986 Mar;35(3):250–253. doi: 10.1016/0026-0495(86)90209-x. [DOI] [PubMed] [Google Scholar]
  15. Zatz R., Brenner B. M. Pathogenesis of diabetic microangiopathy. The hemodynamic view. Am J Med. 1986 Mar;80(3):443–453. doi: 10.1016/0002-9343(86)90719-9. [DOI] [PubMed] [Google Scholar]
  16. de Oliveira F. Pericytes in diabetic retinopathy. Br J Ophthalmol. 1966 Mar;50(3):134–143. doi: 10.1136/bjo.50.3.134. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES